Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 2 , Pages 141-146 , March 2008

Androgen deprivation therapy for prostate cancer: Effects on hand function

  • Feray Soyupek, M.D.

      Affiliations

    • Department of Physical Medicine and Rehabilitation, Suleyman Demirel University School of Medicine, Isparta, Turkey
    • ,
  • Sedat Soyupek, M.D.

      Affiliations

    • Department of Urology, Suleyman Demirel University School of Medicine, Isparta, Turkey
    • ,
  • Hakkı Perk, M.D.

      Affiliations

    • Department of Urology, Suleyman Demirel University School of Medicine, Isparta, Turkey
    • ,
  • Alper Özorak, M.D.

      Affiliations

    • Department of Urology, Suleyman Demirel University School of Medicine, Isparta, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90-246-2112456; fax: +90-246-2371762.

Received 18 September 2006 ,Revised 13 December 2006 ,Accepted 14 December 2006.

References 

  1. American Cancer Society. Cancer Facts and Figures 2004. Atlanta, GA: American Cancer Society; 2004;Available at: www.cancer.org. Accessed September 13, 2006.
  2. Klotz L. Hormone therapy for patients with prostate carcinoma. Cancer. 2000;88:3009–3014
  3. Schröder FH. Hormonal therapy of prostate cancer. In:  Walsh PC,  Retik AB,  Vaughan ED, et al. editor. Campbell’s urology. Philadelphia (PA): Saunders; 2002;p. 3190–3195
  4. Conn PM, Hsueh AJ, Crowley WF. Gonadotropin releasing hormone: Molecular and cell biology, physiology, and clinical applications. Fed Proc. 1984;43:2351–2361
  5. Griggs RC, Kingston W, Jozefowicz RF, et al. Effect of testosterone on muscle mass and muscle protein synthesis. J Appl Physiol. 1989;66:498–503
  6. Brodsky IG, Balagopal P, Nair KS. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men: A clinical research center study. J Clin Endocrinol Metab. 1996;8:3469–3475
  7. Kadi F, Bonnerud P, Eriksson A, et al. The expression of androgen receptors in human neck and limb muscles: Effects of training and self-administration of androgenic-anabolic steroids. Histochem Cell Biol. 2000;113:25–29
  8. Herbst KL, Bhasin S. Testosterone action on skeletal muscle. Curr Opin Clin Nutr Metab Care. 2004;7:271–277
  9. Arnold AM, Peralta JM, Thonney ML. Ontogeny of growth hormone, insulin-like growth factor-I, estradiol and cortisol in the growing lamb: Effect of testosterone. J Endocrinol. 1996;150:391–399
  10. Bonifazi M, Ginanneschi F, Volpe R, et al. Effects of gonadal steroids on the input-output relationship of the corticospinal pathway in humans. Brain Res. 2004;1011:187–194
  11. Lopez-Alvarenga JC, Reyes-Diaz S, Castillo-Martinez L, et al. Reproducibility and sensitivity of a questionnaire on physical activity in a Mexican population. [in Spanish] Salud Publica Mex. 2001;43:306–312
  12. Fess EE, Moran CA. Clinical assessment recommendations. In: 2nd ed.. Chicago (IL): American Society of Hand Therapists; 1992;p. 41–46
  13. Mathiowetz V, Rennells C, Donahoe L. Effect of the elbow position on grip and key pinch strength. Hand Surg [Am]. 1985;10:694–697
  14. Ruff RM, Parker SB. Gender- and age-specific changes in motor speed and eye-hand coordination in adults: Normative values for the Finger Tapping and Grooved Pegboard Tests. Percept Mot Skill. 1993;76:1219–1230
  15. Duruoz MT, Cerrahoglu L, Dincer-Turhan Y, et al. Hand function assessment in patients receiving haemodialysis. Swiss Med Wkly. 2003;9(133):433–438
  16. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571
  17. Haapaniemi TH, Sotaniemi KA, Sintonen H, et al. The generic 15D instrument is valid and feasible for measuring health related quality of life in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2004;75:976–983
  18. Akinci F, Yildirim A, Ogutman B, et al. Translation, cultural adaptation, initial reliability, and validation of Turkish 15D’s version: A generic health-related quality of life (HRQoL) instrument. Eval Health Prof. 2005;28:53–66
  19. Sheffield-Moore M. Androgens and the control of skeletal muscle protein synthesis. Ann Med. 2000;32:181–186
  20. Ferrando AA, Tipton KD, Doyle D, et al. Testosterone injection stimulates net protein synthesis but not tissue amino acid transport. Am J Physiol Endocrinol Metab. 1998;275:864–871
  21. Singh R, Artaza JN, Taylor WE, et al. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology. 2003;144:5081–5088
  22. Fryburg DA. Insulin-like growth factor I exerts growth hormone- and insulin-like actions on human muscle protein metabolism. Am J Physiol. 1994;267:331–336
  23. Katznelson L, Finkelstein JS, Schoenfeld DA, et al. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab. 1996;81:4358–4365
  24. Urban RJ, Bodenburg YH, Gilkison C, et al. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol. 1995;269:820–826
  25. Ferrando AA, Sheffield-Moore M, Yeckel CW, et al. Testosterone administration to older men improves muscle function: Molecular and physiological mechanisms. Am J Physiol Endocrinol Metab. 2002;282:601–607
  26. Basaria S, Lieb J, Tang AM, et al. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol (Oxf). 2002;56:779–786
  27. Burris AS, Banks SM, Carter CS, et al. A long-term prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men. J Androl. 1992;13:297–304
  28. Barrett-Connor E, Von Mühlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: The Rancho Bernardo Study. J Clin Endocrinol Metab. 1999;84:573–577
  29. Yesavage JA, Davidson J, Widrow L, et al. Plasma testosterone levels, depression, sexuality, and age. Biol Psychiatry. 1985;20:222–225
  30. Higano CS, Ellis W, Russell K, et al. Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: A pilot study. Urology. 1996;48:800–804

PII: S1078-1439(06)00323-1

doi: 10.1016/j.urolonc.2006.12.014

Urologic Oncology: Seminars and Original Investigations
Volume 26, Issue 2 , Pages 141-146 , March 2008

Article Tools